Multifocal Choroiditis with Panuveitis





History of Present Illness


A 25-year-old woman with no past medical history and a long-standing history of myopia presents for the first time to the eye clinic complaining of distorted vision in her right eye (OD). She first noticed that her vision was a little blurry about a month ago, which also coincided with more floaters than she is used to. She had assumed that these symptoms were insignificant and would resolve, but then 2 weeks later she noticed a grayed-out area of vision paracentrally OD, so she decided to present to the eye clinic.



Exam










































OD OS
Visual acuity 20/40 20/20
Intraocular pressure (IOP) 18 19
Sclera/conjunctiva White and quiet White and quiet
Cornea Clear Clear
Anterior chamber (AC) 2+ white cells Deep and quiet
1+ flare
Iris Unremarkable Unremarkable
Lens Clear Clear
Anterior vitreous 2+ white cells Clear




Dilated Fundus Examination (DFE) (See Fig. 28.1 )


















Nerve Cup-to-disc (c/d) 0.1, peripapillary
atrophy
Macula Lacquer cracks
Vessels Normal caliber and course
Periphery Unremarkable



Fig. 28.1


Color fundus photograph of the right eye shows lacquer cracks and a small submacular hemorrhage. There were no peripheral lesions.

Modified from Schroeder K, Meyer-ter-Vehn T, Fassnacht-Riederle H, Guthoff R. Course of disease in multifocal choroiditis lacking sufficient immunosuppression: A case report. J Med Case Rep 2016;10:298.


Questions to Ask





  • Have you noticed anything in the left eye (OS)?



  • Have you had any recent illnesses or hospitalizations?



  • Are you having or have you recently had any other symptoms in the rest of your body, such as joint pains, new rashes, breathing problems, problems with bowel movements, or oral or genital ulcers?



  • Have you had any tick bites recently?



  • Have you ever traveled outside the country?



  • Have you had any trauma or surgery to the eye?



  • Do you use injection drugs?



  • Do you practice safe sex?



  • What is your glasses prescription?



The patient answers no to the first seven questions. She has always used barrier protection during sex. She hands over her glasses, and the Rx is −9.00 +0.75×180 OD, −8.50 +0.50×145 OS.


Fluorescein angiography (FA) and optical coherence tomography (OCT) were pursued to further investigate the cause of metamorphopsia and subretinal hemorrhage ( Fig. 28.2 ).




Fig. 28.2


Fluorescein angiogram of the right eye shows early hyperfluorescence in the area of the lacquer crack, as well as multiple hypofluorescent spots in areas where there were no funduscopically visible lesions ( left panel, early frame ), suggestive of occult choroiditis. In the late frame ( right panel ), the area of early, discrete hyperfluorescence has increased in size and intensity, suggestive of choroidal neovascularization. OCT OD ( not shown ) confirmed the presence of shallow subretinal fluid.

Modified from Schroeder K, Meyer-ter-Vehn T, Fassnacht-Riederle H, Guthoff R. Course of disease in multifocal choroiditis lacking sufficient immunosuppression: A case report. J Med Case Rep 2016;10:298.


Assessment





  • Panuveitis with occult multifocal choroiditis (MFCPU) by angiography OD



  • Choroidal neovascularization OD



  • High myopia OU with secondary lacquer cracks



Differential Diagnosis





  • Idiopathic



  • Sarcoidosis



  • Syphilis



  • Less likely: tuberculosis, atypical Mycobacteria , subacute fungal infection



Working Diagnosis





  • Noninfectious MFCPU, but rule out infectious causes before starting therapy.



  • The patient has no risk factors for common infectious causes of multifocal choroiditis, nor is she immunosuppressed. Her young age, female gender, and myopic refraction are classic for idiopathic MFCPU.



Testing





  • FA and OCT already performed, as noted earlier



  • Indocyanine green (ICG) (not performed) is a superior test for identifying areas of choroiditis



  • Check fluorescent treponemal antibody absorption (FTA-ABS), rapid plasma reagin (RPR), QuantiFERON or purified protein derivative (PPD), angiotensin-converting enzyme (ACE), lysozyme, and chest x-ray (CXR)



Management





  • Start prednisone 60 mg by mouth (PO) daily once infectious laboratory tests are negative



  • Prednisolone acetate 1% four times a day (QID) OD, cyclopentolate 1% twice a day (BID) OD



  • Defer anti–vascular endothelial growth factor (VEGF) treatment for now, as new inflammatory choroidal neovascularization (CNV) will often respond to antiinflammatory therapy



  • Follow up in 2 weeks



Follow-up


The patient has the appropriate diagnostic tests performed, all of which are negative. However, she does not return to the clinic as scheduled in 2 weeks, nor does she reschedule.


She returns 8 months later complaining of severe loss of vision OD. She admits that she never started the prednisone, as prescribed, and only used the eye drops intermittently. However, she is now very concerned about her vision ( Figs. 28.3 and 28.4 ).


Apr 3, 2021 | Posted by in OPHTHALMOLOGY | Comments Off on Multifocal Choroiditis with Panuveitis

Full access? Get Clinical Tree

Get Clinical Tree app for offline access